1) Hepatic veins occlusion
肝静脉阻断
1.
Conclusions Hepatic veins occlusion for severe hepatic trauma is safe,effective to prevent dangerous bleeding and air embolism with less interference to hemodynamics than total hepatic blood occlusion.
目的探讨肝静脉阻断技术在救治严重肝脏创伤中的临床应用价值。
4) THVEPC
不阻断下腔静脉的全肝血流阻断
1.
Objective To evaluate the effect to total hepatic vascular exclusion with preservation of the caval flow(THVEPC)on the resection of liver tumors.
目的探讨不阻断下腔静脉的全肝血流阻断切肝术的应用价值。
5) portal vein blocking
门静脉阻断
1.
Objective To investigate the effect of long-time portal vein blocking on liver and gut at normothermia temporarily and their correlations,determine whether portal vein blood can reflow into systemic circulation by portal-systemic collaterals.
目的观察常温下长时间门静脉阻断再通后对肝脏、肠道的影响及与阻断时间的关系,明确有无门体侧枝开放及与门静脉阻断耐受性的关系。
2.
Objective To investigate the effect on liver and gut after long-time portal vein blocking at normothermia temporarily and their correlations ,determine whether portal vein blood can reflow into systemic circulation by portal-systemic collaterals.
目的观察常温下长时间门静脉阻断再通后对肝脏、肠道结构功能的影响及其与阻断时间的关系,明确有无门体侧枝开放及其与门静脉阻断耐受性的关系。
6) Hepatic veno-occlusive disease
肝静脉阻塞病
1.
Research advances on prevention and treatment of hepatic veno-occlusive disease subsequent hematopoietic stem cell transplantation;
造血干细胞移植并发肝静脉阻塞病防治的研究进展
2.
Objective Hepatic veno-occlusive disease(HVOD)is one of the most serious complications after allogenic hematopoietic stem cell transplantation(allo-SCT).
目的研究低剂量肝素联合前列腺素E1(PGE1)预防重型β-地中海贫血患儿异基因造血干细胞移植后的肝静脉阻塞病(hepatic veno-occlusive disease,HVOD)的临床效果。
补充资料：肝外阻塞性胆汁性肝硬化
肝外阻塞性胆汁性肝硬化
又称"继发性胆汁性肝硬化。*胆汁性肝硬化的一个类型，继发于肝外胆管阻塞而引起的肝硬化。主要由总胆管结石、手术后胆管狭管、胰头癌、先天性胆管闭锁或缺如等原因所造成。在梗阻上端的胆道由下而上地逐渐扩大迂曲，胆汁淤积，肝内小胆管扩大而破裂，使肝血管受压，胆汁外渗，肝细胞发生缺血、坏死，纤维组织增生，最后形成肝硬化。临床表现为黄疸、肝脾肿大，皮肤粘膜出血倾向，血胆固醇下降等，晚期表现同*肝硬化。解除肝外阻塞原因，本病有治愈的可能性。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条